{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportid": "4349802-0", "transmissiondateformat": "102", "transmissiondate": "20050107", "serious": "1", "seriousnessdeath": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20040429", "receiptdateformat": "102", "receiptdate": "20040319", "fulfillexpeditecriteria": "1", "companynumb": "AT-BRISTOL-MYERS SQUIBB COMPANY-12537346", "primarysource": { "qualification": "5" }, "sender": { "senderorganization": "FDA-Public Use" }, "receiver": null, "patient": { "patientonsetage": "66", "patientonsetageunit": "801", "patientsex": "2", "patientdeath": { "patientdeathdateformat": null, "patientdeathdate": null }, "reaction": [ { "reactionmeddrapt": "ANAEMIA" }, { "reactionmeddrapt": "ASTHENIA" }, { "reactionmeddrapt": "FAECALOMA" }, { "reactionmeddrapt": "OVARIAN CANCER" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "CARBOPLATIN", "drugdosagetext": "CYCLE 1: 30-OCT-2003", "drugadministrationroute": "042", "drugindication": "OVARIAN CANCER", "drugstartdateformat": "102", "drugstartdate": "20040204", "drugenddateformat": "102", "drugenddate": "20040204", "drugtreatmentduration": "98", "drugtreatmentdurationunit": null, "openfda": { "application_number": [ "ANDA077861", "ANDA076517", "ANDA077059", "ANDA207324", "NDA219921", "ANDA077269", "ANDA205487", "ANDA206775", "ANDA077266" ], "brand_name": [ "CARBOPLATIN", "KYXATA" ], "generic_name": [ "CARBOPLATIN" ], "manufacturer_name": [ "Apotex Corp.", "Hospira, Inc.", "Gland Pharma Limited", "Teyro Labs Private Limited", "Avyxa Pharma, LLC", "Teva Parenteral Medicines, Inc.", "Natco Pharma USA LLC", "Eugia US LLC", "Accord Healthcare, Inc.", "BPI Labs LLC", "Fresenius Kabi USA, LLC" ], "product_ndc": [ "60505-6282", "61703-150", "61703-360", "61703-262", "61703-600", "68083-190", "68083-191", "68083-192", "68083-193", "82511-003", "82511-004", "82511-005", "82511-006", "83831-141", "83831-140", "83831-142", "0703-4239", "0703-4244", "0703-4246", "0703-4248", "69339-364", "69339-365", "69339-366", "69339-367", "61703-339", "55150-333", "55150-334", "55150-335", "55150-386", "16729-295", "54288-164", "54288-165", "54288-166", "54288-167", "63323-172" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS" ], "substance_name": [ "CARBOPLATIN" ], "rxcui": [ "597195", "2721602" ], "spl_id": [ "0e68e276-b0df-4f03-e063-6394a90a22b9", "5aa72c15-8033-4559-b257-373371b18958", "5af07c55-5bef-4da3-91fa-9b3d8d1253d3", "2b3f8994-659d-b905-e063-6394a90a3aec", "5c711945-70be-42f4-b153-e1459dd9929c", "bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df", "4c89cedc-e48b-445c-ad05-54dbe60e4fb0", "0ddf4411-7138-412a-908a-fadf22bdfb79", "6029d051-ee8d-44cc-8dae-b91c3385d4c3", "35cf6068-f31a-211b-e063-6294a90a6b53", "b943761e-6a46-45a0-bdb4-1fec1e101f8c", "c0a7463c-d90f-4060-a54e-6a4888e8af0e", "3a1dd588-13b0-4d58-8d46-3a25a4fc6b40", "5abfcb87-bb02-4384-9c9d-7d0e3e809311" ], "spl_set_id": [ "1c275825-0275-4c73-b650-e4c1519f13b8", "47677091-fd20-49af-933c-c9dd2be21de9", "9eb057eb-29ce-40d2-9ac8-ed107f25f5ab", "f64a0cbe-7fe3-407e-8933-21c30e1a1ebc", "f91c48da-68d1-4aa7-89b8-d84a3e8b629b", "f330f5a2-2cad-402f-bcbb-26245a753276", "4c89cedc-e48b-445c-ad05-54dbe60e4fb0", "c3ae9880-44bb-4f4e-93d8-8a5e21708a30", "f5fe9a20-47a5-45b9-ab06-c6158d9b6aca", "48aa7ef3-9f44-2a08-e054-00144ff88e88", "e176b6ef-2ff6-498b-a9d8-7a634d147f37", "5484d2f0-0cc2-4bba-8f26-c7f6539a9606", "b4fa7aac-c9d2-4af4-a281-3e6cfc502ff6", "5abfcb87-bb02-4384-9c9d-7d0e3e809311" ], "package_ndc": [ "60505-6282-1", "60505-6282-3", "60505-6282-6", "60505-6282-7", "61703-360-18", "61703-150-05", "61703-262-05", "61703-600-05", "68083-190-01", "68083-191-01", "68083-192-01", "68083-193-01", "82511-004-15", "82511-003-05", "82511-005-45", "82511-006-60", "83831-140-02", "83831-141-08", "83831-142-50", "0703-4244-01", "0703-4246-01", "0703-4248-01", "0703-4239-01", "69339-364-05", "69339-365-15", "69339-366-45", "69339-367-60", "61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56", "55150-333-01", "55150-334-01", "55150-335-01", "55150-386-01", "16729-295-31", "16729-295-33", "16729-295-34", "16729-295-12", "16729-295-38", "0703-4244-81", "0703-4246-81", "0703-4248-81", "0703-4239-81", "54288-165-01", "54288-166-01", "54288-167-01", "54288-164-01", "63323-172-60", "55150-335-00", "55150-386-00" ], "nui": [ "N0000175413", "N0000175073" ], "pharm_class_epc": [ "Platinum-based Drug [EPC]" ], "unii": [ "BG3F62OND5" ] } }, { "drugcharacterization": "1", "medicinalproduct": "PACLITAXEL", "drugdosagetext": "CYCLE 1: 30-OCT-2003", "drugadministrationroute": "042", "drugindication": "OVARIAN CANCER", "drugstartdateformat": "102", "drugstartdate": "20040204", "drugenddateformat": "102", "drugenddate": "20040204", "drugtreatmentduration": "98", "drugtreatmentdurationunit": null, "openfda": { "application_number": [ "NDA021660", "ANDA207326", "ANDA216355", "NDA211875", "ANDA075184", "NDA216338", "ANDA213434", "ANDA217877", "ANDA076131", "ANDA216874", "ANDA077574", "ANDA212700", "ANDA091540" ], "brand_name": [ "ABRAXANE", "PACLITAXEL PACLITAXEL", "PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND)", "PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND", "PACLITAXEL" ], "generic_name": [ "PACLITAXEL", "PACLITAXEL (AIBUMIN-BOUND)" ], "manufacturer_name": [ "Abraxis BioScience, LLC", "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.", "BluePoint Laboratories", "NorthStar Rx LLC", "American Regent, Inc.", "Teva Parenteral Medicines, Inc.", "Teva Pharmaceuticals, Inc.", "Mylan Institutional LLC", "Hospira, Inc.", "Alembic Pharmaceuticals Inc.", "Meitheal Pharmaceuticals Inc.", "Ningbo Shuangcheng Pharmaceutical Co., Ltd", "Northstar Rx LLC", "Gland Pharma Limited", "Fresenius Kabi USA, LLC", "Sagent Pharmaceuticals", "Sandoz Inc", "Natco Pharma USA LLC", "Alembic Pharmaceuticals Limited", "Novadoz Pharmaceuticals LLC" ], "product_ndc": [ "68817-134", "23155-882", "23155-883", "23155-884", "68001-651", "72603-408", "0517-4300", "0703-3213", "0703-3216", "0703-3218", "0480-3290", "68001-516", "67457-937", "61703-015", "61703-342", "68001-705", "62332-620", "62332-621", "62332-622", "71288-183", "0703-3217", "75007-041", "16714-137", "68083-178", "68083-179", "68083-180", "63323-763", "25021-255", "0781-3531", "69339-227", "69339-228", "69339-229", "46708-620", "46708-621", "46708-622", "72205-061", "72205-062", "72205-063" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS" ], "substance_name": [ "PACLITAXEL" ], "rxcui": [ "583214", "583218", "312199" ], "spl_id": [ "d1c7770f-7099-4ad3-84e2-20e638cb224e", "d4a15d93-5bab-4208-aa87-66131fd901cb", "3c3af5f5-c5d8-a6a1-e063-6294a90a68e7", "1b25114a-fb04-4ec5-a5c0-6868f36116d6", "5db1c7ab-35c2-4764-b1ae-33f44560883b", "ea88ff78-f7f3-44cd-90d4-ff010fd4ee47", "2fbc2699-cf99-497c-94b9-8a2c534c061f", "395353d9-d8e9-a4df-e063-6394a90ac9a4", "a7b44e58-9df3-4a4e-b521-99f4d4149457", "d6785e15-24f0-4649-904d-ee6acb216061", "523b8199-fcb1-57d3-e063-6294a90aabca", "9a4e25af-2c07-46c8-a9f2-28ba744c8117", "ab2be690-a801-46c1-a254-213c3893fc24", "26567d69-d05c-44e5-b3ca-e4504aa3c8a6", "c455b438-d057-4568-a66a-68775a878fdc", "1f5ca3d3-f137-4efe-91d1-11fac6e8ebb1", "aeff20f1-c4e7-46c6-a6cb-f0aab334571b", "11fa3178-16bd-4da3-b276-079ce8e12efb", "5f3284c1-d03f-4fca-bb78-1ead3280af60", "374cacf2-c5ef-4958-e063-6294a90a5b3c", "3adcb50c-5c38-4e6b-91f9-a776b843ed47", "6d04b514-c85c-4db1-919e-21dd98172791", "4e1bf850-d616-4ff3-b62a-2057dddc3dfe" ], "spl_set_id": [ "24d10449-2936-4cd3-b7db-a7683db721e4", "b4c5d08a-e0f5-4af1-97d6-213705adedf1", "36d4a2ed-4b34-4b06-e063-6394a90acc86", "1e9d5093-fbfc-470a-8520-811c46a8870c", "f06d1bb3-83f1-4d84-8004-4c6681ad8a5a", "fbd32bd2-9685-41cb-bee2-730a45526b65", "15dd51ed-29e8-468b-b6d1-21b1f84d6f2e", "9e7bc2c2-a369-4c6f-9dd9-ee98ddaae833", "a1a06de1-d9a4-460a-b87d-5e40305b065c", "ea28753a-8631-460a-bfdc-b101eb8ac84a", "59906bd2-8337-4cd8-9288-65b90eac2a7a", "0c12c77c-5fd4-48dc-a318-e96892233992", "31e893aa-8d9e-4576-8614-eb2fe772bde4", "e4be6cbf-72b9-4f7f-9b1b-459b2d35961a", "4df3fda6-0b29-420e-ab91-81441ce914ed", "e47c2c34-0466-4219-be6f-97e4231ed55f", "fec9ddee-53a9-4a61-ad0a-be6b604de084", "a6c24189-293f-42ca-b969-75870bb55af0", "5721b9bf-c3c1-4b73-b96c-5fbe3147b6a5", "15ca4829-8fee-45f9-b4bc-b31c15732cd6", "a1eb16b4-285b-4e81-9c4e-1244d4a52af8", "6d04b514-c85c-4db1-919e-21dd98172791", "4e1bf850-d616-4ff3-b62a-2057dddc3dfe" ], "package_ndc": [ "68817-134-50", "23155-882-31", "23155-883-31", "23155-884-31", "68001-651-37", "72603-408-01", "0517-4300-01", "0703-3213-81", "0703-3216-81", "0703-3218-81", "0480-3290-01", "68001-516-27", "67457-937-50", "61703-342-09", "61703-342-22", "61703-342-50", "61703-015-04", "68001-705-27", "62332-620-05", "62332-621-17", "62332-622-50", "71288-183-50", "0703-3213-01", "0703-3216-01", "0703-3217-01", "0703-3218-01", "75007-041-01", "16714-137-01", "68083-178-01", "68083-179-01", "68083-180-01", "63323-763-05", "63323-763-16", "63323-763-50", "25021-255-05", "25021-255-17", "25021-255-50", "0781-3531-91", "69339-227-05", "69339-228-17", "69339-229-50", "46708-620-05", "46708-621-17", "46708-622-50", "72205-061-01", "72205-062-01", "72205-063-01" ], "nui": [ "N0000175085", "N0000175592" ], "pharm_class_pe": [ "Microtubule Inhibition [PE]" ], "pharm_class_epc": [ "Microtubule Inhibitor [EPC]" ], "unii": [ "P88XT4IS4D" ] } }, { "drugcharacterization": "1", "medicinalproduct": "INTERFERON GAMMA", "drugdosagetext": "INITIAL DOSE: 30-OCT-2003", "drugadministrationroute": "058", "drugindication": "OVARIAN CANCER", "drugstartdateformat": "102", "drugstartdate": "20040204", "drugenddateformat": "102", "drugenddate": "20040221", "drugtreatmentduration": "115", "drugtreatmentdurationunit": null }, { "drugcharacterization": "2", "medicinalproduct": "NABILONE", "openfda": { "application_number": [ "NDA018677" ], "brand_name": [ "CESAMET" ], "generic_name": [ "NABILONE" ], "manufacturer_name": [ "Bausch Health US LLC" ], "product_ndc": [ "0187-1231" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "NABILONE" ], "rxcui": [ "104885", "311891" ], "spl_id": [ "c8ba6520-445a-4934-85f4-6f706cb21585" ], "spl_set_id": [ "83c7ac15-ece9-47de-b83c-d575544fa449" ], "package_ndc": [ "0187-1231-50" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "2N4O9L084N" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PANTOLOC" }, { "drugcharacterization": "2", "medicinalproduct": "ZOFRAN" }, { "drugcharacterization": "2", "medicinalproduct": "MAGNOSOLV", "drugstartdateformat": "102", "drugstartdate": "20031212" } ] } } ] }